JP Morgan Chase’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,600
| Closed | -$983K | – | 7584 |
|
|
2025
Q4 | $983K | Sell |
3,600
-200
| -5% | -$54.3K | ﹤0.01% | 4624 |
|
|
2025
Q3 | $1.03M | Sell |
3,800
-25,000
| -87% | -$6.8M | ﹤0.01% | 4566 |
|
|
2025
Q2 | $7.94M | Buy |
28,800
+25,200
| +700% | +$6.85M | ﹤0.01% | 2751 |
|
|
2025
Q1 | $955K | Sell |
3,600
-6,700
| -65% | -$1.65M | ﹤0.01% | 4385 |
|
|
2024
Q4 | $2.39M | Sell |
10,300
-52,500
| -84% | -$12.1M | ﹤0.01% | 4012 |
|
|
2024
Q3 | $13.9M | Buy |
62,800
+4,500
| +8% | +$931K | ﹤0.01% | 2322 |
|
|
2024
Q2 | $11.5M | Buy |
58,300
+45,500
| +355% | +$9.4M | ﹤0.01% | 2336 |
|
|
2024
Q1 | $2.76M | Sell |
12,800
-9,500
| -43% | -$2M | ﹤0.01% | 3588 |
|
|
2023
Q4 | $4.7M | Sell |
22,300
-10,200
| -31% | -$2.18M | ﹤0.01% | 3157 |
|
|
2023
Q3 | $6.51M | Buy |
32,500
+8,500
| +35% | +$1.69M | ﹤0.01% | 2636 |
|
|
2023
Q2 | $4.45M | Hold |
24,000
| – | – | ﹤0.01% | 2952 |
|
|
2023
Q1 | $4.6M | Buy |
24,000
+7,300
| +44% | +$1.32M | ﹤0.01% | 2889 |
|
|
2022
Q4 | $2.81M | Hold |
16,700
| – | – | ﹤0.01% | 3299 |
|
|
2022
Q3 | $2.96M | Hold |
16,700
| – | – | ﹤0.01% | 3160 |
|
|
2022
Q2 | $3.42M | Sell |
16,700
-29,400
| -64% | -$6.23M | ﹤0.01% | 3108 |
|
|
2022
Q1 | $11M | Buy |
46,100
+33,800
| +275% | +$7.94M | ﹤0.01% | 2275 |
|
|
2021
Q4 | $2.81M | Sell |
12,300
-14,900
| -55% | -$3.28M | ﹤0.01% | 3556 |
|
|
2021
Q3 | $5.26M | Buy |
27,200
+5,700
| +27% | +$1.15M | ﹤0.01% | 2990 |
|
|
2021
Q2 | $4.57M | Buy |
21,500
+20,200
| +1,554% | +$4.26M | ﹤0.01% | 3132 |
|
|
2021
Q1 | $265K | Buy |
+1,300
| New | +$256K | ﹤0.01% | 5031 |
|
|
2020
Q1 | – | Sell |
-25,800
| Closed | -$5.18M | – | 5344 |
|
|
2019
Q4 | $5.18M | Hold |
25,800
| – | – | ﹤0.01% | 2644 |
|
|
2019
Q3 | $5.45M | Hold |
25,800
| – | – | ﹤0.01% | 2633 |
|
|
2019
Q2 | $5M | Hold |
25,800
| – | – | ﹤0.01% | 2655 |
|
|
2019
Q1 | $4.25M | Hold |
25,800
| – | – | ﹤0.01% | 2715 |
|
|
2018
Q4 | $4.85M | Sell |
25,800
-55,000
| -68% | -$10.2M | ﹤0.01% | 2597 |
|
|
2018
Q3 | $13.8M | Buy |
80,800
+25,800
| +47% | +$4.34M | ﹤0.01% | 1944 |
|
|
2018
Q2 | $9.02M | Hold |
55,000
| – | – | ﹤0.01% | 2229 |
|
|
2018
Q1 | $8.9M | Hold |
55,000
| – | – | ﹤0.01% | 2112 |
|
|
2017
Q4 | $8.03M | Buy |
+55,000
| New | +$7.83M | ﹤0.01% | 2296 |
|
|
2015
Q1 | – | Sell |
-2,400
| Closed | -$213K | – | 4081 |
|
|
2014
Q4 | $213K | Sell |
2,400
-13,500
| -85% | -$1.14M | ﹤0.01% | 4008 |
|
|
2014
Q3 | $1.27M | Buy |
+15,900
| New | +$1.2M | ﹤0.01% | 3187 |
|
Other funds holding CME
VCM
VPM
JP Morgan Chase's CME Position: Q1 2026 in Review
JP Morgan Chase increased its CME Group (CME) stake by 10% in Q1 2026, buying an estimated $329M and bringing the position to 12,209,761 shares worth $3.63B. The position accounts for 0.23% of the portfolio, ranked #93.
JP Morgan Chase first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- JP Morgan Chase held 12,209,761 shares of CME Group worth $3.63B as of Q1 2026.
- JP Morgan Chase bought 1,108,304 CME Group shares in Q1 2026, an estimated $329M.
- CME Group made up 0.23% of JP Morgan Chase's portfolio in Q1 2026, its #93 holding.
- JP Morgan Chase first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.